Literature DB >> 20615867

Innate immune signaling induces high levels of TC-specific deaminase activity in primary monocyte-derived cells through expression of APOBEC3A isoforms.

Beth K Thielen1, John P McNevin, M Juliana McElrath, Brook Vander Stoep Hunt, Kevin C Klein, Jaisri R Lingappa.   

Abstract

In HIV-1-infected individuals, G-to-A hypermutation is found in HIV-1 DNA isolated from peripheral blood mononuclear cells (PBMCs). These mutations are thought to result from editing by one or more host enzymes in the APOBEC3 (A3) family of cytidine deaminases, which act on CC (APOBEC3G) and TC (other A3 proteins) dinucleotide motifs in DNA (edited cytidine underlined). Although many A3 proteins display high levels of deaminase activity in model systems, only low levels of A3 deaminase activity have been found in primary cells examined to date. In contrast, here we report high levels of deaminase activity at TC motifs when whole PBMCs or isolated primary monocyte-derived cells were treated with interferon-alpha (IFNalpha) or IFNalpha-inducing toll-like receptor ligands. Induction of TC-specific deaminase activity required new transcription and translation and correlated with the appearance of two APOBEC3A (A3A) isoforms. Knockdown of A3A in monocytes with siRNA abolished TC-specific deaminase activity, confirming that A3A isoforms are responsible for all TC-specific deaminase activity observed. Both A3A isoforms appear to be enzymatically active; moreover, our mutational studies raise the possibility that the smaller isoform results from internal translational initiation. In contrast to the high levels of TC-specific activity observed in IFNalpha-treated monocytes, CC-specific activity remained low in PBMCs, suggesting that A3G deaminase activity is relatively inhibited, unlike that of A3A. Together, these findings suggest that deaminase activity of A3A isoforms in monocytes and macrophages may play an important role in host defense against viruses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20615867      PMCID: PMC2934643          DOI: 10.1074/jbc.M110.102822

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  80 in total

1.  Population level analysis of human immunodeficiency virus type 1 hypermutation and its relationship with APOBEC3G and vif genetic variation.

Authors:  Craig Pace; Jean Keller; David Nolan; Ian James; Silvana Gaudieri; Corey Moore; Simon Mallal
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  APOBEC3 proteins inhibit human LINE-1 retrotransposition.

Authors:  Heide Muckenfuss; Matthias Hamdorf; Ulrike Held; Mario Perkovic; Johannes Löwer; Klaus Cichutek; Egbert Flory; Gerald G Schumann; Carsten Münk
Journal:  J Biol Chem       Date:  2006-05-30       Impact factor: 5.157

3.  Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic mice.

Authors:  Ai Kotani; Naoki Kakazu; Tatsuaki Tsuruyama; Il-mi Okazaki; Masamichi Muramatsu; Kazuo Kinoshita; Hitoshi Nagaoka; Daisuke Yabe; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-24       Impact factor: 11.205

Review 4.  Clinical aspects of parvovirus B19 infection.

Authors:  K Broliden; T Tolfvenstam; O Norbeck
Journal:  J Intern Med       Date:  2006-10       Impact factor: 8.989

5.  STAT1-independent cell type-specific regulation of antiviral APOBEC3G by IFN-alpha.

Authors:  Phuong Thi Nguyen Sarkis; Songcheng Ying; Rongzhen Xu; Xiao-Fang Yu
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

6.  Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family.

Authors:  Ying Dang; Xiaojun Wang; Walter J Esselman; Yong-Hui Zheng
Journal:  J Virol       Date:  2006-08-18       Impact factor: 5.103

7.  Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G.

Authors:  David H Nguyen; Suryaram Gummuluru; Jianming Hu
Journal:  J Virol       Date:  2007-02-21       Impact factor: 5.103

8.  Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation.

Authors:  Kun Luo; Tao Wang; Bindong Liu; Chunjuan Tian; Zuoxiang Xiao; John Kappes; Xiao-Fang Yu
Journal:  J Virol       Date:  2007-04-11       Impact factor: 5.103

9.  Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration.

Authors:  Jean L Mbisa; Rebekah Barr; James A Thomas; Nick Vandegraaff; Irene J Dorweiler; Evguenia S Svarovskaia; William L Brown; Louis M Mansky; Robert J Gorelick; Reuben S Harris; Alan Engelman; Vinay K Pathak
Journal:  J Virol       Date:  2007-04-11       Impact factor: 5.103

10.  All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition.

Authors:  Masanobu Kinomoto; Takayuki Kanno; Mari Shimura; Yukihito Ishizaka; Asato Kojima; Takeshi Kurata; Tetsutaro Sata; Kenzo Tokunaga
Journal:  Nucleic Acids Res       Date:  2007-04-16       Impact factor: 16.971

View more
  66 in total

1.  APOBEC3 proteins and genomic stability: the high cost of a good defense.

Authors:  Iñigo Narvaiza; Sébastien Landry; Matthew D Weitzman
Journal:  Cell Cycle       Date:  2012-01-01       Impact factor: 4.534

2.  The PKC/NF-κB signaling pathway induces APOBEC3B expression in multiple human cancers.

Authors:  Brandon Leonard; Jennifer L McCann; Gabriel J Starrett; Leah Kosyakovsky; Elizabeth M Luengas; Amy M Molan; Michael B Burns; Rebecca M McDougle; Peter J Parker; William L Brown; Reuben S Harris
Journal:  Cancer Res       Date:  2015-09-29       Impact factor: 12.701

Review 3.  Functions and regulation of the APOBEC family of proteins.

Authors:  Harold C Smith; Ryan P Bennett; Ayse Kizilyer; William M McDougall; Kimberly M Prohaska
Journal:  Semin Cell Dev Biol       Date:  2011-10-06       Impact factor: 7.727

Review 4.  APOBECs and virus restriction.

Authors:  Reuben S Harris; Jaquelin P Dudley
Journal:  Virology       Date:  2015-03-26       Impact factor: 3.616

5.  D316 is critical for the enzymatic activity and HIV-1 restriction potential of human and rhesus APOBEC3B.

Authors:  Rebecca M McDougle; Judd F Hultquist; Alex C Stabell; Sara L Sawyer; Reuben S Harris
Journal:  Virology       Date:  2013-03-29       Impact factor: 3.616

6.  Endogenous APOBEC3A DNA cytosine deaminase is cytoplasmic and nongenotoxic.

Authors:  Allison M Land; Emily K Law; Michael A Carpenter; Lela Lackey; William L Brown; Reuben S Harris
Journal:  J Biol Chem       Date:  2013-05-02       Impact factor: 5.157

7.  Clustered and genome-wide transient mutagenesis in human cancers: Hypermutation without permanent mutators or loss of fitness.

Authors:  Steven A Roberts; Dmitry A Gordenin
Journal:  Bioessays       Date:  2014-02-26       Impact factor: 4.345

8.  Cellular HIV-1 inhibition by truncated old world primate APOBEC3A proteins lacking a complete deaminase domain.

Authors:  Miki Katuwal; Yaqiong Wang; Kimberly Schmitt; Kejun Guo; Kalani Halemano; Mario L Santiago; Edward B Stephens
Journal:  Virology       Date:  2014-09-28       Impact factor: 3.616

9.  The ssDNA Mutator APOBEC3A Is Regulated by Cooperative Dimerization.

Authors:  Markus-Frederik Bohn; Shivender M D Shandilya; Tania V Silvas; Ellen A Nalivaika; Takahide Kouno; Brian A Kelch; Sean P Ryder; Nese Kurt-Yilmaz; Mohan Somasundaran; Celia A Schiffer
Journal:  Structure       Date:  2015-04-23       Impact factor: 5.006

10.  Characterization of the Catalytic Domain of Human APOBEC3B and the Critical Structural Role for a Conserved Methionine.

Authors:  Sachini U Siriwardena; Thisari A Guruge; Ashok S Bhagwat
Journal:  J Mol Biol       Date:  2015-08-14       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.